These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31747382)

  • 21. Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.
    Zhang J; Peng F; Li N; Liu Y; Xu Y; Zhou L; Wang J; Zhu J; Huang M; Gong Y
    Radiat Oncol; 2012 Jun; 7():93. PubMed ID: 22713587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients].
    Malhaire JP; Lozac'h P; Simon H; Labat JP; Topart P; Lucas B; Metges JP; Lamezec B
    Bull Cancer; 1997 Apr; 84(4):357-67. PubMed ID: 9238158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Esophageal cancer: outcome according to therapeutic strategy].
    Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
    Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).
    Chiu PW; Chan AC; Leung SF; Leong HT; Kwong KH; Li MK; Au-Yeung AC; Chung SC; Ng EK
    J Gastrointest Surg; 2005; 9(6):794-802. PubMed ID: 16187480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized squamous-cell cancer of the esophagus: retrospective analysis of three treatment schedules.
    Delcambre C; Jacob JH; Pottier D; Gignoux M; Ollivier JM; Vie B; Roussel A; Segol P
    Radiother Oncol; 2001 May; 59(2):195-201. PubMed ID: 11325449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma.
    Murakami M; Kuroda Y; Nakajima T; Okamoto Y; Mizowaki T; Kusumi F; Hajiro K; Nishimura S; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):277-84. PubMed ID: 10487546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.
    Ordu AD; Nieder C; Geinitz H; Scherer V; Kup PG; Schuster T; Combs SE; Fakhrian K
    Anticancer Res; 2014 Dec; 34(12):7255-61. PubMed ID: 25503157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy.
    Chiu CH; Chen WH; Wen YW; Yeh CJ; Chao YK; Chang HK; Tseng CK; Liu YH
    Dis Esophagus; 2016 Aug; 29(6):634-41. PubMed ID: 26175202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
    Modesto A; Dalmasso C; Lusque A; Vieillevigne L; Izar F; Moyal E; Carrère N; Guimbaud R; Rives M
    Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus.
    Uno T; Isobe K; Kawakami H; Ueno N; Shimada H; Matsubara H; Okazumi S; Nabeya Y; Shiratori T; Kawata T; Ochiai T; Ito H
    Dis Esophagus; 2007; 20(1):12-8. PubMed ID: 17227304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
    Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
    Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
    Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.
    Farinella E; Safar A; Nasser HA; Bouazza F; Liberale G; Paesmans M; Marechal R; Van Laethem JL; Hendlisz A; VanHoutte P; El Nakadi I
    J Surg Oncol; 2016 Dec; 114(7):833-837. PubMed ID: 27778349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.
    Yoo C; Park JH; Yoon DH; Park SI; Kim HR; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Kim YH; Kim SB
    Ann Thorac Surg; 2012 Dec; 94(6):1862-8. PubMed ID: 22959577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.